Stockreport

Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update

Mainz Biomed B.V.  (MYNZ) 
PDF Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in Europe Operating loss decreased by 30% and net loss by 18%, driv [Read more]